Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Cash generated from core business operations
3Y CAGR
-54.4%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.01M | +127.7% |
| 2024 | $-3.64M | -114.1% |
| 2023 | $25.89M | +142.5% |
| 2022 | $10.68M | +112.7% |
| 2021 | $-83.75M | -52.1% |
| 2020 | $-55.05M | -26.2% |
| 2019 | $-43.61M | -52.7% |
| 2018 | $-28.55M | -43.2% |
| 2017 | $-19.94M | -7.9% |
| 2016 | $-18.47M | - |